Logo-ps

 

Follower of ICMJE

Powered by:
Pharm Sci. 2023;29(1): 75-83. doi: 10.34172/PS.2022.17

Research Article

Designing a Topical Nanoliposomal Formulation of Ruxolitinib Phosphate

Atefeh Naeimifar 1 ORCID, Saman Ahmad Nasrollahi 2 * ORCID, Hamid Akbari Javar 1, Mansoor Nassiri Kashani 2, Alireza Firooz 2, Mohamadreza Rouini 1

Cited by CrossRef: 2

1- Naeimifar A, Ahmad Nasrollahi S, Samadi A, Aryanian Z, Akbari Javar H, Rouini M, Nassiri Kashani M, Firooz A. Evaluation of tolerability and efficacy of a topical emulgel containing nanoliposomal ruxolitinib phosphate in the treatment of mild atopic dermatitis: a before-after single group pilot study. Journal of Dermatological Treatment. 2022;33(8):3160 [Crossref]
2- Shelke O, Gadge S, Nadaf S, Nimse K, Pingale R. Enhancing topical ruxolitinib delivery via emulgel for vitiligo: formulation development, in vitro release, skin permeation, and mechanistic effects on melanogenesis. Chem Pap. 2026; [Crossref]

   Indexing & Abstracting: